|
SUBSPECIALTY CERTIFICATION IN DERMATOPATHOLOGY
Subspecialty certification in Dermatopathology is a joint
and equal function of the American Board of Dermatology (ABD)
and the American Board of Pathology (ABP). Such function will
relate to qualifications of candidates, standards of examination,
and the form of the certificate. Beginning in 2006, Dermatopathology certificates will have a 10-year time limit.
All candidates applying to sit for this certifying examination
must hold a currently valid, full and unrestricted license
to practice medicine or osteopathy in the state or province of his/her residence in either the United States
or Canada. The candidate may be denied certification if his/her license has been revoked, suspended, restricted, or surrendered in any jurisdiction - or if the candidate is subject to adverse licensure proceedings.
All candidates for this certification must satisfy the following
requirements:
- Prerequisites
- Primary certification by both the American Board of
Dermatology and the American Board of Pathology (anatomic
pathology or anatomic and clinical pathology) or
- Primary certification by either the American Board
of Dermatology or the American Board of Pathology (anatomic
pathology or anatomic and clinical pathology), and the
satisfactory completion of one year of training in dermatopathology
in a program accredited for such training (see below)
by the Accreditation Council for Graduate Medical Education (ACGME). The dermatologist
applicant must spend one-half of the required training
time in pathology. The pathologist applicant must spend
one-half of the required training time in clinical dermatology.
- Training
Accredited institutional training programs in dermatopathology
are an equal and joint function of the Departments of Dermatology
and Pathology of that institution. Training programs in
dermatopathology are reviewed and accredited by the Residency
Review Subcommittee for Dermatopathology, which includes
three members from the Residency Review Committee for Dermatology
and three members from the Residency Review Committee for
Pathology. Upon recommendation by this subcommittee, training
programs in dermatopathology are accredited by conjoint
action of the Residency Review Committees for Dermatology
and Pathology acting with authority delegated by the Accreditation
Council for Graduate Medical Education (ACGME). Information
concerning accredited dermatopathology training programs
may be found in the AMA Graduate Medical Education Directory
or at www.acgme.org. It is the responsibility of directors of fellowships in Dermatopathology to make certain that their trainees file a preliminary registration form in the Board office by August 1st or within 30 days of the start of training.
- Leave of Absence Policy for American Board of Dermatology Subspecialty Fellowship Training
- In general, high priority should be given to completing 12 continuous months of full time training.
- Any departure from (1), for example time lost for a medical leave of absence, should be documented and fully justified in the trainee evaluation forms filed by the training program director with the Board.
- It is necessary that 11 months of training are completed in order to qualify for subspecialty certification. Thus, without exception, any absence (inclusive of vacation) resulting in less than 11 months of training during a 12-month program will require an additional period of training to achieve 11 total months. Only when this requirement is documented by the program director will the trainee be qualified to take the subspecialty certifying examination. If the program director anticipates that this additional training will be completed in a satisfactory manner before September 1, the Board may allow the trainee to take the certifying examination in that year.
- Examination - Deadline for Application and Date of Examination
Candidates who have satisfied the above requirements are
eligible to apply to the Board to take the examination for
subspecialty certification in Dermatopathology, which is
a comprehensive assessment of the candidates' knowledge
of dermatopathology, including the related basic sciences,
and laboratory and clinical areas pertaining to this discipline.
Dermatologist candidates planning to take the subspecialty certification
examination should request an application from the office
of the Executive Director of the American Board of Dermatology. Applications can also be downloaded (click on "Candidate Application" above).
The deadline for receipt of applications is May 1st of the
year in which the candidate plans to take the examination.
The next examination will be given on Wednesday, September 16, 2009 in Tampa, Florida. The deadline for receipt of applications is May 1, 2008. The fee for the 2008 examination is $1,800. The fee may be sent in the form of a check or credit card number (the Board accepts American Express, MasterCard and VISA).
- Appeals Process
An appeals procedure similar to that described for the certification process in dermatology
is available for candidates for subspecialty certification
in Dermatopathology who were declared ineligible by the Board for Dermatopathology
or who failed the Dermatopathology examination.
Candidates submitting such appeals should contact the Board
for current additional information.
- Maintenance of Certification
Certification in Dermatopathology is time-limited for 10 years. When a candidate is certified in Dermatopathology, he/she will enter into
Maintenance of Certification for the 10-year period. See the Maintenance of Certification requirements
|
JOINT POLICY COMMITTEE
FOR DERMATOPATHOLOGY
John V. Collin, M.D.*, Chair (ABP)
Terry L. Barrett, M.D. Vice Chair(ABD)
Thomas D. Horn, M.D. (ABD)
James W. Patterson, M.D. (ABD)
Robert McKenna, M.D.*,(ABP)
Sharon A. Weiss, M.D.* (ABP)
Betsy D. Bennett, M.D.* (Staff, ABP)
Antoinette F. Hood, M.D. (Staff, ABD) |
DERMATOPATHOLOGY TEST DEVELOPMENT AND ADVISORY COMMITTEE
Terry L. Barrett, M.D., Co-Chair (ABD)
Sharon A. Weiss, M.D., Co-Chair (ABP)
Steven D. Billings, M.D.* (ABP)
John A. Carlson, M.D.*, (ABP)
Marsha L. Chaffins, M.D.* (ABD)
Dirk M. Elston, M.D.* (ABD)
Joan Guitart, M.D.* (ABD)
Jeff D. Harvell, M.D.* (ABP)
Beth S. Ruben, M.D.* (ABD)
Oscar P. Sangueza, M.D.* (ABP)
Betsy D. Bennett, M.D.* (Staff, ABP)
Antoinette F. Hood, M.D. (Staff, ABD) |
*Non-ABD
or non-ABP Director members of the Test Committee. |
|
|